Compare BMHL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMHL | MBOT |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Hong Kong | United States |
| Employees | 9 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.8M | 114.9M |
| IPO Year | N/A | 2000 |
| Metric | BMHL | MBOT |
|---|---|---|
| Price | $4.40 | $2.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 3.7K | ★ 1.9M |
| Earning Date | 06-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $119.77 |
| P/E Ratio | $66.66 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.72 | $1.60 |
| 52 Week High | $4.48 | $4.62 |
| Indicator | BMHL | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 66.26 | 50.00 |
| Support Level | $3.25 | $1.65 |
| Resistance Level | $4.48 | $2.28 |
| Average True Range (ATR) | 0.23 | 0.15 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 98.82 | 60.71 |
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.